Unknown OBSERVATIONAL NCT05167630

Prognosis Factors in Patients With Primary Central Nervous System Lymphoma

Sponsor: Zhengzhou University

Updated 4 times since 2022 Last updated: Dec 12, 2021 Started: Sep 1, 2013 Primary completion: Dec 15, 2021 Completion: Dec 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on PCNSL and Survival Analysis, this trial is ongoing. The trial is conducted by Zhengzhou University and has accumulated 4 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2022 — Jan 2024 [monthly]

Recruiting

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zhengzhou University

Data source: Zhengzhou University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zhengzhou, China